Janssen Pharmaceutica N.V., Belgium
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Janssen Pharmaceutica N.V., Belgium sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Janssen Pharmaceutica N.V., Belgium: 6 sponsored US clinical trials, none currently recruiting.
Janssen Pharmaceutica N.V., Belgium sponsors 6 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Critical Confirmed Coronavirus Disease (COVID)-19, with 1 trials.
Upper-quartile sponsor footprint
Janssen Pharmaceutica N.V., Belgium sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
6 total, page 1 of 1
A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
NCT06544616
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer
NCT04557059
A Study of JNJ-55308942 in the Treatment of Bipolar Depression
NCT05328297
A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19
NCT04380961
Study to Assess the Acceptability of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed-Dose Combination (FDC) Tablets in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Pediatric Participants, Using Matching Placebo Tablets
NCT04006704
Idylla IFV-RSV Panel Clinical Testing
NCT02786381
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 1 |
Therapeutic Areas
How the Janssen Pharmaceutica N.V., Belgium early-phase archive is shaped
6 indexed studies, none listed as recruiting (0% open); 4 completed (67%).
Phase mix: 1 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Critical Confirmed Coronavirus Disease (COVID)-19 (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Janssen Pharmaceutica N.V., Belgium: archived-pipeline peers nationwide
Peers matched on 6 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Janssen Pharmaceutica N.V., Belgium sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 archived trials
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
- 3 Waves Wellness · 0% recruiting · 2 trials
Related
What to do with this Janssen Pharmaceutica N.V., Belgium page
6 registered trials is a research-attention snapshot, not an endorsement of Janssen Pharmaceutica N.V., Belgium or any single study.
- None of Janssen Pharmaceutica N.V., Belgium's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Critical Confirmed Coronavirus Disease (COVID)-19 is the condition Janssen Pharmaceutica N.V., Belgium studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Critical Confirmed Coronavirus Disease (COVID)-19 trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Janssen Pharmaceutica N.V., Belgium pipeline card: 6 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.